|
C1D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.31060000002825E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.50380000000828E-05 |
| Normal-vs-Stage2 |
8.03390000000404E-05 |
| Normal-vs-Stage3 |
2.564200E-04 |
| Normal-vs-Stage4 |
1.27639999680795E-08 |
| Stage1-vs-Stage2 |
1.592570E-01 |
| Stage1-vs-Stage3 |
7.393200E-01 |
| Stage1-vs-Stage4 |
1.183140E-03 |
| Stage2-vs-Stage3 |
3.195400E-01 |
| Stage2-vs-Stage4 |
1.864980E-01 |
| Stage3-vs-Stage4 |
9.324100E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56212999999905E-05 |
| Normal-vs-AfricanAmerican |
5.556200E-02 |
| Normal-vs-Asian |
2.976200E-04 |
| Caucasian-vs-AfricanAmerican |
3.687000E-01 |
| Caucasian-vs-Asian |
7.703800E-01 |
| AfricanAmerican-vs-Asian |
3.518000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24039999996428E-07 |
| Normal-vs-Female |
5.96880000000022E-05 |
| Male-vs-Female |
6.157600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.952000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.95840000003245E-06 |
| Normal-vs-Age(61-80Yrs) |
1.48349999995467E-06 |
| Normal-vs-Age(81-100Yrs) |
1.547160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.880980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.140000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.180400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.948570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.094400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.942800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.637800E-01 |
| Classical-VS-Follicular |
1.544150E-01 |
| Classical-VS-Other |
5.461800E-01 |
| Classical-VS-Normal |
4.48499999999852E-05 |
| Tall-VS-Follicular |
6.249000E-01 |
| Tall-VS-Other |
7.325000E-01 |
| Tall-VS-Normal |
1.919620E-03 |
| Follicular-VS-Other |
9.585000E-01 |
| Follicular-VS-Normal |
4.19820000000515E-05 |
| Other-VS-Normal |
2.845600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73321999999976E-05 |
| Normal-vs-N1 |
5.61839999999592E-05 |
| N0-vs-N1 |
4.180400E-01 |
|
|
